These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9432297)
1. [Microalbuminuria as a prognostic marker of cardiovascular diseases]. Lisowska-Myjak B Pol Merkur Lekarski; 1997 Jul; 3(13):28-9. PubMed ID: 9432297 [TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. Pedrinelli R; Dell'Omo G; Di Bello V; Pontremoli R; Mariani M J Hum Hypertens; 2002 Feb; 16(2):79-89. PubMed ID: 11850764 [TBL] [Abstract][Full Text] [Related]
3. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y; Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132 [TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria and cardiovascular risk. Karalliedde J; Viberti G Am J Hypertens; 2004 Oct; 17(10):986-93. PubMed ID: 15485765 [TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. Donnelly R; Yeung JM; Manning G J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161 [TBL] [Abstract][Full Text] [Related]
7. Urinary albumin and cardiovascular profile in the middle-aged population. Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257 [TBL] [Abstract][Full Text] [Related]
8. [Microalbuminuria in diabetes: setting the points for treatment]. Lehnert H; Klose S; Lobmann R; Zehnder D MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185 [TBL] [Abstract][Full Text] [Related]
9. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?]. Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277 [No Abstract] [Full Text] [Related]
12. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. Pontremoli R; Leoncini G; Viazzi F; Ratto E; Vaccaro V; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S112-4. PubMed ID: 16565232 [TBL] [Abstract][Full Text] [Related]
14. Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength? de Jong PE; Gansevoort RT; Bakker SJ J Nephrol; 2007; 20(4):375-80. PubMed ID: 17879201 [TBL] [Abstract][Full Text] [Related]
15. A study on micro-albuminuria--an independent risk factor for vasculopathy in diabetes mellitus. Basu AK; Pal SK; Banerjee R; Mandal S J Indian Med Assoc; 2005 Jul; 103(7):374-5, 382. PubMed ID: 16366190 [TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria as an early marker for cardiovascular disease. de Zeeuw D; Parving HH; Henning RH J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327 [TBL] [Abstract][Full Text] [Related]
18. Slowing progression along the renal disease continuum. Kopyt NP J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338 [TBL] [Abstract][Full Text] [Related]
19. Microalbuminuria: do we need a new threshold? Zamora CR; Cubeddu LX J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737 [TBL] [Abstract][Full Text] [Related]
20. [Microalbuminuria is an early marker for increased morbidity and mortality]. Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]